Proteome Sciences Conditionally Raises £2.5M | GenomeWeb

NEW YORK (GenomeWeb) – Proteome Sciences said today it has conditionally raised £2.5 million ($3.9 million) through the placement of nearly 13.9 new ordinary shares of the company's stock. 

The shares were priced at 18 pence. Proteome Sciences will apply to place the shares for trading on the London Stock Exchanges' AIM on or around July 2, the company said. 

Proteome Sciences Executive Chairman Christopher Pearce has subscribed to about 1.8 million shares in the placement, while Vulpes Investment Management Private has subscribed to nearly 2.6 million shares. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.